NYULMC CareSmarts Pilot
Completed · Not applicable
Conditions studied: Diabetes, Type 2 Diabetes (T2D)
In brief
CareSmarts is a theory-driven behavioral intervention designed to improve self-care among patients with Type 2 diabetes (T2D) with poor glycemic control (HbA1c\>8%), through multiple mediators, including cuing, education, self-efficacy, social support, and health beliefs. Individuals will be randomly assigned with equal allocation to either the CareSmarts intervention or to usual care for 6 months.
Key facts
- Study ID
- NCT02726217
- Run by
- NYU Langone Health
- People needed
- 26
- Starts
- 2016-03-01
- Expected to finish
- 2017-05-02
- Last updated by the study team
- 2017-05-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- have a DRG Code of T2D, and be prescribed at least one oral T2D drug and/or insulin.
- must own an SMS capable mobile device and be willing to send and receive SMS messages regarding T2D self-management.
- The participant's physician of record will have verified that his/her patient can safely participant in an intervention study that targets an HbA1c <7%.
You may not qualify if…
- unable or unwilling to provide informed consent
- unable to participate meaningfully in an intervention that involves use of SMS messages (e.g., due to uncorrected sight impairment, illiterate, non-English-speaking)
- unwilling to accept randomization assignment
- pregnant, plans to become pregnant in the next 6 months, or who become pregnant during the study
- gestational diabetes
- breastfeedling
- individuals who are institutionalized (e.g., in a nursing home or personal care facility, or those who are incarcerated and have limited control over self-management)
Where it is running
- New York University School of Medicine — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.